Arcutis Biotherapeutics (ARQT)'s 30-day implied volatility (IV30) was 43.0% at the close on November 16, 2026, up from 41.4% the day before, against a 52-week range of 28.0% to 75.1%. Its 20-day historical volatility was 53.5%.
Data as of November 16, 2026.